By Famous India
Source - Google Search
A sub-variant of the BA.2.86 lineage of SARS-CoV-2, first identified in India in December 2023, carries the S:L455S mutation and three mutations in non-S proteins
The S:L455S mutation in JN.1 may boost virus spread and evade immunity, but with limited data on severity, ongoing monitoring is essential
A sub-variant of the BA.2.86 lineage of SARS-CoV-2, first identified in India in December 2023, carries the S:L455S mutation and three mutations in non-S proteins
JN.1 symptoms include fever, cough, fatigue, runny nose, and sore throat, with occasional reports of nausea, vomiting, and diarrhea
Keep up with vaccinations and boosters, wear a mask outside, maintain distance, especially when unwell, and practice frequent handwashing or sanitizer use
Follow official health updates from WHO and Indian agencies, avoid unverified information, and prioritize preventive measures according to public health guidelines
Reported cases in the US, China, and Singapore lead to potential travel restrictions from India, with global health agencies closely coordinating responses
Research on JN.1, developing new treatments and vaccines, goes hand in hand with efforts to strengthen healthcare systems and infrastructure